Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2024

Aug 10, 2024

30561_dirs_2024-08-09_e1b7c653-e126-47ab-b7df-46196b84d3da.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2024-08-07

Reporting Person: Hessekiel Jeffrey (EVP, General Counsel & Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-07 Common Stock M 80000 $24.41 Acquired 710325 Direct
2024-08-07 Common Stock S 80000 $25.97 Disposed 630325 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-07 Option (right to buy) $24.41 M 80000 Disposed 2024-10-02 Common Stock (80000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 999 Indirect

Footnotes

F1: Includes 236,022 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 29, 2024.

F3: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.95 to $26.07. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.

F4: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 7, 2024.

F5: The option, representing the right to purchase a total of 100,000 shares of Exelixis, Inc. common stock became fully exercisable on October 3, 2021.